Preview

Medical alphabet

Advanced search
Open Access Open Access  Restricted Access Subscription or Fee Access

Skin microbiome of patients with moderate acne treated with a fixed combination of “benzoyl peroxide 5% + clindamycin 1%” in combination with photodynamic therapy

https://doi.org/10.33667/2078-5631-2025-8-61-68

Abstract

Background. Vulgar acne is one of the most common dermatoses, affecting up to 85% of people aged 12 to 24 years. Four main links are distinguished in the pathogenesis of the disease, including inflammation and pathogenic activity of cutibacteria (Cutibacterium acnes), as well as other microorganisms (Staphylococcus and Malassezia spp).

Objective of the study. To study the facial skin microbiome in patients with moderate acne using gas chromatography-mass spectrometry before and after therapy with a fixed combination of «benzoyl peroxide (BP) 5% + clindamycin 1%» in combination with photodynamic therapy. Materials and methods. The skin microbiome of 40 patients (24 men, 16 women) with an established diagnosis of moderate acne was studied using gas chromatography-mass spectrometry (GC–MS) before and after (3 months) therapy. By randomization, two therapeutic groups were formed in equal numbers and gender ratios (12 men and 8 women, respectively) – the main group, which received a fixed combination of «benzoyl peroxide 5% + clindamycin 1%» (Zerkalin Intensive gel) in combination with photodynamic therapy, and a comparison group (monotherapy with «Zerkalin Intensive» gel). In addition to the qualitative and quantitative analysis by microorganism types, an assessment was made of the ratio of results for grouped microorganisms (loads of resident, transient, aerobic, anaerobic biota, loads of gram-positive and gram-negative bacteria, total bacterial load).

Results. It was found that in patients with acne, the total bacterial load (TBL) in the compared groups was exceeded by 8% and 7.9%, respectively. In both therapeutic groups, pronounced dysbiosis was revealed, which was characterized by an imbalance between total aerobes and anaerobes. Contamination with the former was exceeded by 310.6% (group I) and 187.5% (group II) (p<0.05), and the contamination with anaerobes, on the contrary, was reduced by 6.9% in group I and increased by 21.3% in group II (p><0.005). The total number of gram-positive bacteria was exceeded by 21.4% (group I) and 9.7% (group II) (p><0.05), gram-negative bacteria were reduced by 90.1% and 89.9% (p>0.5), respectively. At the end of 3 months of treatment, the quantitative indices of all six aerobes and four anaerobes of the resident microbiota in both groups returned to values close to the normative indices characteristic of healthy skin (p> 0.05). The greatest reduction in both therapeutic groups was observed in Propionibacterium spp. (by 90.4% and 78.8%, respectively (p<0.05)). A more pronounced reduction in the colonies of anaerobes of the transient microbiota over 12 weeks of therapy was observed in the main therapeutic group: Propionibacterium acnes was in the lead (78.4% versus 68.9% in group II, p><0.05). In the main therapeutic group, the reduction in resident biota contamination slightly prevailed over that in the comparison group (70.5% in group I and 68.9% in group II (p> 0.05).

Conclusion. Treatment of patients with moderate acne using a fixed combination of «benzoyl peroxide 5% + clindamycin 1%» in combination with photodynamic therapy has a significantly more pronounced effect on the elimination of anaerobes of both resident and transient microbiota.

About the Authors

O. Yu. Olisova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Olisova Olga Yu., DM Sci (habil.), professor, RAS corresponding member

Moscow



A.  V. Shepeleva
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Shepeleva Anastasia V.

Moscow



M. V. Kail
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Kail Maria V., PhD Med.

Moscow



References

1. Tan J.K., Bhate K. A global perspective on the epidemiology of acne. Br. J. Dermatol.– 2015; 172 (Suppl. 1): 3–12. DOI: 10.1111/bjd.13462

2. Kubanov A.A., Sysoeva T.A., Bisharova A.S., Mertsalova I.B. Aspects of the pathogenesis and modern therapy of acne. Attending physician. 2016; Vol.: 30–38. (In Russ.).

3. Sidorenko E.E., Lvov A.N. Modern trends in the study of acne pathogenesis. Pharmateka. 2021; 28 (14): 10–14. (In Russ.). DOI: 10.18565/pharmateca.2021.14.10–14

4. Cardenas-de la Garza J.A., Haidari W., Feldman S.R. Microbiome, probiotics and dermatology. Br.J. Dermatol. 2020; 182 (Suppl. 1): 8–9. DOI: 10.1111/bjd.18350

5. Del Rosso J.Q., Kircik L. The primary role of sebum in the pathophysiology of acne vulgaris and its therapeutic relevance in acne management. J. Dermatolog. Treat. 2024; 35 (Suppl. 1): 22–29. DOI: 10.1080/09546634.2023.2296855.

6. Burtseva G.N., Sergeev A. Yu., Arzumanyan V.G., Sergeev Yu. Yu. Perifollicular skin microbiota in acne. Part I. General characteristics of colonization and resistance to systemic antibiotics. Immunopathology, allergology, infectology. 2013; 2: 84–93. (In Russ.).

7. Yang Y., Qu L., Mijakovic I., Wei Y. Advances in the human skin microbiota and its roles in cutaneous diseases. Microb. Cell. Fact. 2022; 21 (1): 176. DOI: 10.1186/s12934 022 01901 6.

8. Dvoryankova E.V., Denieva M.I., Khismatullina Z.R. Skin microbiome in patients with acne. Medical Council. 2023; 14: 45–50.– https://doi.org/10.21518/ms2023–264

9. Yu Y., Dunaway S., Champer J., Kim J., Alikhan A. Changing our microbiome: probiotics in dermatology. Br.J. Dermatol. 2020; 182 (Suppl. 1): 39–46. (In Russ.). DOI: 10.1111/bjd.18088

10. Chilicka K., Dziendziora-Urbinska I., Szygula R., Asanova B., Nowicka D. Microbiome and Probiotics in Acne Vulgaris . A Narrative Review. Life (Basel). 2022; 12 (Suppl. 3): 422. DOI: 10.3390/life12030422

11. Schneider A.M., Nolan Z.T., Banerjee K., Paine A.R., Cong Z., Gettle S.L., Longenecker A.L., Zhan X., Agak G.W., Nelson A.M. Evolution of the facial skin microbiome during puberty in normal and acne skin. J. Eur. Acad. Dermatol. Venereol. 2023; 37 (Suppl. 1): 166–175. DOI: 10.1111/jdv.18616

12. Dreno B., Martin R., Moyal D., Henley J.B., Khammari A., Seité S. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne. Exp. Dermatol. 2017; 26 (Suppl. 9): 798–803. DOI: 10.1111/exd.13296

13. Christensen G.J., Scholz C.F., Enghild J., Rohde H., Kilian M., Thürmer A., Brzuszkiewicz E., Lomholt H.B., Brüggemann H. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis. BMC Genomics. 2016; 29 (Suppl. 17): 152. DOI: 10.1186/s12864 016 2489 5

14. Wang Y., Kuo S., Shu M., Yu J., Huang S., Dai A., Two A., Gallo R.L., Huang C.M. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Appl. Microbiol. Biotechnol. 2014; 98 (Suppl. 1): 411–24. DOI: 10.1007/s00253 013 5394 8

15. Lebedev A. T., Artemenko K.A., Samgina T. Yu. Basics of Mass Spectrometry of Proteins and Peptides. Moscow: Tekhnosfera; 2012. (In Russ.).

16. Olisova O. Yu., Shepeleva A. V., Kayumova L. N. Experience with the Use of Benzoyl Peroxide Gel and Clindamycin in the Treatment of Mild to Moderate Acne // Russian Journal of Skin and Venereal Diseases. 2023; 26 (6): 605–621. (In Russ.). DOI: https://doi.org/10.17816/dv611037

17. Schaller M., Sebastian M., Ress C., et al. A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris // J Eur Acad Dermatol Venereol. 2016; 30 (6): 966–973. DOI: 10.1111/jdv.13541

18. Andreev D.A., Zavyalov A.A., Ermolaeva T.N., Fisun A.G., Polyakova K.I., Dubovtseva V.A., Maksimova T.E. Photodynamic therapy is a current medical technology in the treatment of acne vulgaris. Bulletin of dermatology and venereology. 2019; 95 (6): 44–54. (In Russ.). https://doi.org/10.25208/0042 4609 2019 95 6 44 54

19. Evdokimova N. V., Shogiradze L. D., Pokhlebkina A. A., Petrenko Yu.V., Mikhnina E. A., Novikova V. P., Bezhenar V. F. Microbiota of the small intestine in obese adolescent girls. Experimental and Clinical Gastroenterology. 2023; 215 (7): 34–41. (In Russ.). DOI: 10.31146/1682–8658-ecg 215 7 34 41

20. Evdokimova N. V., Shogiradze L.D., Pokhlebkina A.A., Petrenko Yu. V., Mikhnina E. A., Novikova V.P., Bezhenar V.F. Small intestinal microbiota in adolescent girls suffering from obesity. Experimental and Clinical Gastroenterology. 2023; 215 (7): 34–41. (In Russ.). DOI: 10.31146/1682–8658-ecg 215 7 34 41

21. Visca P., Seifert H., Towner K.J. Acinetobacter infection – an emerging threat to human health. IUBMB Life. 2011; 63 (12): 1048–1054.

22. Silina L. V., Bibicheva T. V., Myatenko N. I., Pereverzeva I. V. Structure, functions and significance of the skin microbiome in norm and in pathological conditions. RMJ. 2018; 8 (II): 92–96. (In Russ.).


Review

For citations:


Olisova O.Yu., Shepeleva A.V., Kail M.V. Skin microbiome of patients with moderate acne treated with a fixed combination of “benzoyl peroxide 5% + clindamycin 1%” in combination with photodynamic therapy. Medical alphabet. 2025;(8):61-68. (In Russ.) https://doi.org/10.33667/2078-5631-2025-8-61-68

Views: 33


ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)